Загрузка...
Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target
BACKGROUND: Malignant mesothelioma is a largely incurable disease that is refractory to current therapies. CD26 is a multifunctional cell surface protein involved in autoimmune disease, diabetes, and cancer. It has a role in T cell function, extracellu-lar protein modification, as a prognostic facto...
Сохранить в:
| Опубликовано в: : | Curr Med Chem |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Bentham Science Publishers
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5737002/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1573394713666170907160734 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|